What is REGN's five-year median EV/Sales?

The median, or middle weekly reading, is 5.3× over the last five years. Available history contains 533 weekly observations from Aug 8, 2016 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.

Regeneron Pharmaceuticals (REGN) valuation history

Within its usual range

As of Oct 22, 2026

REGN's EV/Sales of 5.1x is lower than 60% of its available weekly readings from the last five years.

Share EV/Sales history

Shared chart range

Preview embed

Chart by stockresearch.app. Reuse with credit under CC BY 4.0.

EV/Sales at year-end

Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.

REGN year-end valuation history
Reading date	EV/Sales	5-year rank
Dec 29, 2025	5.4×	39%
Dec 30, 2024	5.5×	22%
Dec 25, 2023	7.0×	78%
Dec 26, 2022	5.6×	37%
Dec 27, 2021	5.0×	12%
Dec 28, 2020	6.8×	39%
Dec 30, 2019	5.9×	24%
Dec 31, 2018	6.8×	31%
Dec 25, 2017	7.7×	2%
Dec 26, 2016	8.7×	Short history

Peers on the same measure

Stock	EV/Sales	5-year rank
ABBVAbbVie	8.7×	100%
AMGNAmgen	7.4×	93%
GILDGilead Sciences	7.0×	98%
INCYIncyte	3.7×	61%

Appears in

Health Care Stocks with Low P/E Ratios and Steady Revenue Growth Stocks Below Their 5-Year Median P/E Stocks Near Their Lowest P/E Ratios in 5 Years

Research on REGN

No published research on REGN yet. Read how valuation percentiles work.

Loading related research…

About this history

What is REGN's current EV/Sales?: REGN's EV/Sales of 5.1x is lower than 60% of its available weekly readings from the last five years.
What is REGN's five-year median EV/Sales?: The median, or middle weekly reading, is 5.3× over the last five years. Available history contains 533 weekly observations from Aug 8, 2016 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.